Ebrahim Rahmani Moghadam
- Cancer Research top 5%
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications 2
-
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 2
- Retinoids in leukemia and cellular processes 2
- Circular RNAs in diseases 2
- Biomaterials top 10%
-
- Cancer Mechanisms and Therapy 3
Ebrahim Rahmani Moghadam
17 papers receiving 940 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 319
- Molecular Medicine 80
- Molecular Biology 568
- Biomaterials 107
- Oncology 170
Countries citing papers authored by Ebrahim Rahmani Moghadam
This map shows the geographic impact of Ebrahim Rahmani Moghadam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebrahim Rahmani Moghadam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebrahim Rahmani Moghadam more than expected).
Fields of papers citing papers by Ebrahim Rahmani Moghadam
This network shows the impact of papers produced by Ebrahim Rahmani Moghadam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebrahim Rahmani Moghadam. The network helps show where Ebrahim Rahmani Moghadam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ebrahim Rahmani Moghadam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2021 | 11 | |
| 4 | 2020 | 79 | |
| 5 | 2020 | 63 | |
| 6 | 2020 | 23 | |
| 7 | 2020 | 72 | |
| 8 | 2020 | 69 | |
| 9 | 2020 | 87 | |
| 10 | 2020 | 62 | |
| 11 | 2020 | 81 | |
| 12 | 2020 | 115 | |
| 13 | 2020 | 122 | |
| 14 | 2020 | 5 | |
| 15 | 2020 | 32 | |
| 16 | 2020 | 63 | |
| 17 | 2020 | 59 | |
| 18 | 2016 | 2 |
About Ebrahim Rahmani Moghadam
Ebrahim Rahmani Moghadam is a scholar working on Molecular Medicine, Cancer Research and Health Information Management, having authored 18 papers that have together received 946 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (3 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), RNA Interference and Gene Delivery (2 papers), Curcumin's Biomedical Applications (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (319 citations), Molecular Medicine (80 citations) and Molecular Biology (568 citations). Ebrahim Rahmani Moghadam has collaborated with scholars based in Iran, Türkiye and Italy. Frequent co-authors include Milad Ashrafizadeh, Ali Zarrabi, Masoud Najafi, Kiavash Hushmandi, Reza Mohammadinejad, Farid Hashemi, Fardin Hashemi, Pooyan Makvandi, Vahideh Zarrin and Amirhossein Zabolian. Their work appears in journals such as Life Sciences, European Journal of Pharmacology and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.